Augmentation therapy is disease modifying in alpha-1 antitrypsin deficiency (AATD). Interim analysis of the RAPID Extension Study

Kenneth Chapman, Jonathan Burdon, Eeva Piitulainen, Robert Sandhaus, Niels Seersholm, James Stocks, Gerard McElvaney

Original language	English
Publication date	2014
Publication status	Published - 2014
Event	ATS San Diego - San Diego, United States Duration: 15 May 2014 → 20 May 2014

Cite this

@conference{b164c24bf42b4283a01ba1a0e2505ec8,

title = "Augmentation therapy is disease modifying in alpha-1 antitrypsin deficiency (AATD). Interim analysis of the RAPID Extension Study",

author = "Kenneth Chapman and Jonathan Burdon and Eeva Piitulainen and Robert Sandhaus and Niels Seersholm and James Stocks and Gerard McElvaney",

year = "2014",

language = "English",

note = "ATS San Diego ; Conference date: 15-05-2014 Through 20-05-2014",

}

TY - ABST

T1 - Augmentation therapy is disease modifying in alpha-1 antitrypsin deficiency (AATD). Interim analysis of the RAPID Extension Study

AU - Chapman, Kenneth

AU - Burdon, Jonathan

AU - Piitulainen, Eeva

AU - Sandhaus, Robert

AU - Seersholm, Niels

AU - Stocks, James

AU - McElvaney, Gerard

PY - 2014

Y1 - 2014

M3 - Conference abstract for conference

T2 - ATS San Diego

Y2 - 15 May 2014 through 20 May 2014

ER -